2021 Q3 Form 10-Q Financial Statement
#000121390021057373 Filed on November 08, 2021
Income Statement
| Concept | 2021 Q3 | 2020 Q3 | 2020 Q2 |
|---|---|---|---|
| Revenue | $110.0K | $0.00 | -$70.00K |
| YoY Change | |||
| Cost Of Revenue | $14.00K | ||
| YoY Change | |||
| Gross Profit | $96.00K | $0.00 | -$70.00K |
| YoY Change | |||
| Gross Profit Margin | 87.27% | ||
| Selling, General & Admin | $4.371M | $490.0K | -$460.0K |
| YoY Change | 792.04% | 226.67% | -518.18% |
| % of Gross Profit | 4553.13% | ||
| Research & Development | $5.946M | $3.790M | $3.350M |
| YoY Change | 56.89% | ||
| % of Gross Profit | 6193.75% | ||
| Depreciation & Amortization | $235.0K | $240.0K | $240.0K |
| YoY Change | -2.08% | ||
| % of Gross Profit | 244.79% | ||
| Operating Expenses | $10.55M | $490.0K | -$3.720M |
| YoY Change | 2052.24% | 226.67% | -3481.82% |
| Operating Profit | -$10.45M | -$490.0K | $3.650M |
| YoY Change | 2032.65% | ||
| Interest Expense | $35.12M | $0.00 | $420.0K |
| YoY Change | -100.0% | 23.53% | |
| % of Operating Profit | 11.51% | ||
| Other Income/Expense, Net | $4.203M | -$3.710M | -$1.130M |
| YoY Change | -213.29% | ||
| Pretax Income | $28.88M | -$480.0K | $3.960M |
| YoY Change | -6115.63% | -500.0% | 1621.74% |
| Income Tax | -$69.00K | ||
| % Of Pretax Income | -0.24% | ||
| Net Earnings | $28.94M | -$480.0K | -$5.819M |
| YoY Change | -6130.0% | -500.0% | -2630.0% |
| Net Earnings / Revenue | 26312.73% | ||
| Basic Earnings Per Share | $0.47 | -$0.59 | |
| Diluted Earnings Per Share | $0.42 | -$0.59 | $120.0K |
| COMMON SHARES | |||
| Basic Shares Outstanding | 62.07M shares | 17.36M shares | |
| Diluted Shares Outstanding | 70.04M shares | 17.36M shares |
Balance Sheet
| Concept | 2021 Q3 | 2020 Q3 | 2020 Q2 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $60.55M | $440.0K | $260.0K |
| YoY Change | 13661.82% | -2.22% | -51.85% |
| Cash & Equivalents | $60.61M | ||
| Short-Term Investments | |||
| Other Short-Term Assets | $3.520M | $90.00K | $10.00K |
| YoY Change | 3811.11% | 50.0% | 0.0% |
| Inventory | $41.00K | ||
| Prepaid Expenses | |||
| Receivables | $68.00K | ||
| Other Receivables | $1.212M | ||
| Total Short-Term Assets | $65.39M | $530.0K | $280.0K |
| YoY Change | 12238.3% | 3.92% | -48.15% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $7.586M | ||
| YoY Change | |||
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $58.00K | $25.59M | $25.28M |
| YoY Change | -99.77% | -46.28% | -46.13% |
| Total Long-Term Assets | $7.644M | $25.59M | $25.27M |
| YoY Change | -70.13% | -46.28% | -46.15% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $65.39M | $530.0K | $280.0K |
| Total Long-Term Assets | $7.644M | $25.59M | $25.27M |
| Total Assets | $73.04M | $26.12M | $25.55M |
| YoY Change | 179.62% | -45.75% | -46.18% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $1.023M | ||
| YoY Change | |||
| Accrued Expenses | $3.379M | $180.0K | $180.0K |
| YoY Change | 1777.22% | 1700.0% | |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $2.010M | $1.700M |
| YoY Change | -100.0% | 336.96% | |
| Long-Term Debt Due | $153.0K | ||
| YoY Change | |||
| Total Short-Term Liabilities | $4.831M | $3.400M | $2.350M |
| YoY Change | 42.09% | 353.33% | 1282.35% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $19.30M | $0.00 | $0.00 |
| YoY Change | |||
| Other Long-Term Liabilities | $43.16M | $1.390M | $1.390M |
| YoY Change | 3004.68% | -24.46% | -24.46% |
| Total Long-Term Liabilities | $62.45M | $1.390M | $1.390M |
| YoY Change | 4392.95% | -24.46% | -24.46% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $4.831M | $3.400M | $2.350M |
| Total Long-Term Liabilities | $62.45M | $1.390M | $1.390M |
| Total Liabilities | $67.35M | $4.790M | $3.740M |
| YoY Change | 1306.08% | 84.94% | 86.07% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | |||
| YoY Change | |||
| Common Stock | |||
| YoY Change | |||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $5.686M | -$87.26M | -$77.17M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $73.04M | $26.12M | $25.55M |
| YoY Change | 179.62% | -45.75% | -46.18% |
Cashflow Statement
| Concept | 2021 Q3 | 2020 Q3 | 2020 Q2 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | $28.94M | -$480.0K | -$5.819M |
| YoY Change | -6130.0% | -500.0% | -2630.0% |
| Depreciation, Depletion And Amortization | $235.0K | $240.0K | $240.0K |
| YoY Change | -2.08% | ||
| Cash From Operating Activities | -$7.305M | -$550.0K | $3.000M |
| YoY Change | 1228.18% | 175.0% | -1864.71% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$241.0K | $80.00K | $170.0K |
| YoY Change | -401.25% | ||
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | |||
| YoY Change | |||
| Cash From Investing Activities | -$241.0K | -$80.00K | -$170.0K |
| YoY Change | 201.25% | ||
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 5.232M | 730.0K | -1.470M |
| YoY Change | 616.71% | 563.64% | -2550.0% |
| NET CHANGE | |||
| Cash From Operating Activities | -7.305M | -550.0K | 3.000M |
| Cash From Investing Activities | -241.0K | -80.00K | -170.0K |
| Cash From Financing Activities | 5.232M | 730.0K | -1.470M |
| Net Change In Cash | -2.314M | 180.0K | 1.530M |
| YoY Change | -1385.56% | -300.0% | -1490.91% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$7.305M | -$550.0K | $3.000M |
| Capital Expenditures | -$241.0K | $80.00K | $170.0K |
| Free Cash Flow | -$7.064M | -$630.0K | $2.830M |
| YoY Change | 1021.27% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001822791 | ||
| CY2021Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.47 | |
| us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
USD | ||
| us-gaap |
Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
|
USD | ||
| CY2020Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.59 | |
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.23 | ||
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.16 | ||
| CY2021Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.42 | |
| CY2020Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.59 | |
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.23 | ||
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-1.16 | ||
| CY2021Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
62071754 | shares |
| CY2020Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
17358159 | shares |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
61307699 | shares | |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
17358159 | shares | |
| CY2021Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
70038634 | shares |
| CY2020Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
17358159 | shares |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
61307699 | shares | |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
17358159 | shares | |
| CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-67774000 | USD |
| CY2020Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-71538000 | USD |
| CY2020Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-77173000 | USD |
| CY2020Q3 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
2000 | USD |
| CY2020Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-87255000 | USD |
| CY2020Q4 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
USD | |
| CY2021Q3 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
USD | |
| CY2020Q4 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
USD | |
| CY2020Q4 | clnn |
Warrant Liability Noncurrent
WarrantLiabilityNoncurrent
|
USD | |
| CY2021Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2020Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2020Q3 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
USD | |
| clnn |
Gain On Extinguishment Of Notes Payable
GainOnExtinguishmentOfNotesPayable
|
USD | ||
| CY2021Q3 | clnn |
Loss On Extinguishment Of Convertible Notes Payable
LossOnExtinguishmentOfConvertibleNotesPayable
|
USD | |
| clnn |
Loss On Extinguishment Of Convertible Notes Payable
LossOnExtinguishmentOfConvertibleNotesPayable
|
USD | ||
| CY2021Q3 | us-gaap |
Gain Loss On Contract Termination
GainLossOnContractTermination
|
USD | |
| CY2020Q3 | us-gaap |
Gain Loss On Contract Termination
GainLossOnContractTermination
|
USD | |
| us-gaap |
Gain Loss On Contract Termination
GainLossOnContractTermination
|
USD | ||
| CY2021Q3 | clnn |
Change In Fair Value Of Preferred Stock Warrant Liability
ChangeInFairValueOfPreferredStockWarrantLiability
|
USD | |
| clnn |
Change In Fair Value Of Preferred Stock Warrant Liability
ChangeInFairValueOfPreferredStockWarrantLiability
|
USD | ||
| CY2021Q3 | clnn |
Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
|
USD | |
| clnn |
Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
|
USD | ||
| CY2020Q3 | clnn |
Change In Fair Value Of Contingent Earnout
ChangeInFairValueOfContingentEarnout
|
USD | |
| clnn |
Change In Fair Value Of Contingent Earnout
ChangeInFairValueOfContingentEarnout
|
USD | ||
| CY2020Q3 | clnn |
Change In Fair Value Of Initial Shareholders Contingent Earnout
ChangeInFairValueOfInitialShareholdersContingentEarnout
|
USD | |
| clnn |
Change In Fair Value Of Initial Shareholders Contingent Earnout
ChangeInFairValueOfInitialShareholdersContingentEarnout
|
USD | ||
| CY2020Q3 | clnn |
Change In Fair Value Of Common Stock Warrant Liability
ChangeInFairValueOfCommonStockWarrantLiability
|
USD | |
| clnn |
Change In Fair Value Of Common Stock Warrant Liability
ChangeInFairValueOfCommonStockWarrantLiability
|
USD | ||
| CY2020Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
USD | |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
USD | ||
| CY2021Q2 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
USD | |
| CY2021Q3 | clnn |
Stock Issued During Period Exercise Of Underwriters Option
StockIssuedDuringPeriodExerciseOfUnderwritersOption
|
USD | |
| CY2021Q3 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
USD | |
| CY2020Q3 | clnn |
Stock Issued During Period Of Series D Preferred Stock
StockIssuedDuringPeriodOfSeriesDPreferredStock
|
USD | |
| CY2020Q3 | us-gaap |
Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
|
USD | |
| us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
USD | ||
| clnn |
Change In Fair Value Of Clene Nanomedicine Contingent Earnouts
ChangeInFairValueOfCleneNanomedicineContingentEarnouts
|
USD | ||
| us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
USD | ||
| us-gaap |
Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
|
USD | ||
| clnn |
Lease Liability Settled Through Termination Of Lease
LeaseLiabilitySettledThroughTerminationOfLease
|
USD | ||
| us-gaap |
Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
|
USD | ||
| clnn |
Issuance Of Series D Preferred Stock Upon Extinguishment Of Convertible Promissory Notes
IssuanceOfSeriesDPreferredStockUponExtinguishmentOfConvertiblePromissoryNotes
|
USD | ||
| clnn |
Changes In Fair Value Of Initial Shareholders Contingent Earnout
ChangesInFairValueOfInitialShareholdersContingentEarnout
|
USD | ||
| us-gaap |
Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
|
USD | ||
| clnn |
Change In Fair Value Of Common Stock Warrant Liabilitys
ChangeInFairValueOfCommonStockWarrantLiabilitys
|
USD | ||
| us-gaap |
Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
|
USD | ||
| us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
USD | ||
| us-gaap |
Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
|
USD | ||
| clnn |
Weighted Average Remaining Term Years Forfeited
WeightedAverageRemainingTermYearsForfeited
|
|||
| clnn |
Series D Redeemable Convertible Preferred Stock
SeriesDRedeemableConvertiblePreferredStock
|
shares | ||
| CY2021Q3 | clnn |
Series C Redeemable Convertible Preferred Stock
SeriesCRedeemableConvertiblePreferredStock
|
shares | |
| us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
USD | ||
| us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
USD | ||
| us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
USD | ||
| us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
USD | ||
| us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
USD | ||
| us-gaap |
Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
|
USD | ||
| CY2020Q3 | us-gaap |
Restricted Cash
RestrictedCash
|
USD | |
| clnn |
Extinguishment Of Derivative Liability In Connection With Extinguishment Of Convertible Promissory N
ExtinguishmentOfDerivativeLiabilityInConnectionWithExtinguishmentOfConvertiblePromissoryN
|
USD | ||
| clnn |
Deferred Offering Costs In Accrued Liabilities
DeferredOfferingCostsInAccruedLiabilities
|
USD | ||
| CY2020Q4 | clnn |
Directors Officers Insurance
DirectorsOfficersInsurance
|
USD | |
| CY2021Q3 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
USD | |
| clnn |
Warrant Liability Recorded At Issuance Of Notes Payable
WarrantLiabilityRecordedAtIssuanceOfNotesPayable
|
USD | ||
| CY2021Q3 | clnn |
Debt Instrument Unamortized Discount Year One
DebtInstrumentUnamortizedDiscountYearOne
|
USD | |
| CY2021Q3 | clnn |
Debt Instrument Unamortized Discount Year Four
DebtInstrumentUnamortizedDiscountYearFour
|
USD | |
| CY2021Q3 | clnn |
Accrued Transaction Costs
AccruedTransactionCosts
|
USD | |
| CY2021Q3 | clnn |
Finance Lease Work In Process Gross
FinanceLeaseWorkInProcessGross
|
USD | |
| CY2020Q4 | us-gaap |
Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
|
USD | |
| CY2020Q4 | us-gaap |
Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
|
USD | |
| CY2021Q3 | clnn |
Debt Instrument Unamortized Discount Remainder Of Fiscal Year
DebtInstrumentUnamortizedDiscountRemainderOfFiscalYear
|
USD | |
| CY2021Q3 | clnn |
Debt Instrument Thereafter
DebtInstrumentThereafter
|
USD | |
| CY2021Q3 | clnn |
Debt Instrument Unamortized Discount Year Five
DebtInstrumentUnamortizedDiscountYearFive
|
USD | |
| clnn |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Intrinsic Value Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsIntrinsicValueGranted
|
USD | ||
| clnn |
Weighted Average Remaining Term Years Exercised
WeightedAverageRemainingTermYearsExercised
|
|||
| clnn |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodIntrinsicValue
|
USD | ||
| CY2021Q3 | clnn |
Series D Redeemable Convertible Preferred Stock
SeriesDRedeemableConvertiblePreferredStock
|
shares | |
| clnn |
Series C Redeemable Convertible Preferred Stock
SeriesCRedeemableConvertiblePreferredStock
|
shares | ||
| CY2021Q3 | clnn |
Series B Redeemable Convertible Preferred Stock
SeriesBRedeemableConvertiblePreferredStock
|
shares | |
| clnn |
Series B Redeemable Convertible Preferred Stock
SeriesBRedeemableConvertiblePreferredStock
|
shares | ||
| CY2021Q3 | clnn |
Series A Redeemable Convertible Preferred Stock
SeriesARedeemableConvertiblePreferredStock
|
shares | |
| clnn |
Series A Redeemable Convertible Preferred Stock
SeriesARedeemableConvertiblePreferredStock
|
shares | ||
| CY2021Q3 | clnn |
Series D Redeemable Convertible Preferred Stock Warrants
SeriesDRedeemableConvertiblePreferredStockWarrants
|
shares | |
| clnn |
Series D Redeemable Convertible Preferred Stock Warrants
SeriesDRedeemableConvertiblePreferredStockWarrants
|
shares | ||
| CY2021Q3 | clnn |
Series A Redeemable Convertible Preferred Stock Warrantsin Shares
SeriesARedeemableConvertiblePreferredStockWarrantsinShares
|
shares | |
| clnn |
Series A Redeemable Convertible Preferred Stock Warrantsin Shares
SeriesARedeemableConvertiblePreferredStockWarrantsinShares
|
shares | ||
| CY2021Q3 | clnn |
Convertible Notes Payables
ConvertibleNotesPayables
|
shares | |
| CY2020Q3 | clnn |
Convertible Notes Payables
ConvertibleNotesPayables
|
shares | |
| clnn |
Convertible Notes Payables
ConvertibleNotesPayables
|
shares | ||
| CY2020Q3 | clnn |
Common Stock Warrants
CommonStockWarrants
|
shares | |
| clnn |
Common Stock Warrants
CommonStockWarrants
|
shares | ||
| CY2020Q3 | clnn |
Unvested Restricted Stock Awards Shares
UnvestedRestrictedStockAwardsShares
|
shares | |
| clnn |
Unvested Restricted Stock Awards Shares
UnvestedRestrictedStockAwardsShares
|
shares | ||
| CY2020Q3 | clnn |
Chardan Unit Purchase Option Warrants
ChardanUnitPurchaseOptionWarrants
|
shares | |
| clnn |
Chardan Unit Purchase Option Warrants
ChardanUnitPurchaseOptionWarrants
|
shares | ||
| CY2020Q3 | clnn |
Clene Nanomedicine Contingent Earnout Shares
CleneNanomedicineContingentEarnoutShares
|
shares | |
| clnn |
Clene Nanomedicine Contingent Earnout Shares
CleneNanomedicineContingentEarnoutShares
|
shares | ||
| CY2020Q3 | clnn |
Initial Shareholders Contingent Earnout Shares
InitialShareholdersContingentEarnoutShares
|
shares | |
| clnn |
Initial Shareholders Contingent Earnout Shares
InitialShareholdersContingentEarnoutShares
|
shares | ||
| CY2018Q3 | clnn |
Exclusive Rights Intellectual Property Term
ExclusiveRightsIntellectualPropertyTerm
|
P5Y |
